Immunofluorescence

Global Immunofluorescence Assay Market to 2030: Increasing Prevalence of Chronic and Infectious Diseases Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 6, 2023
Research, Science, HIV/AIDS, Fluorophore, Prevalence, HIV, COVID-19, Microscopy, Infection, Chron, Crohn's disease, Antibody, CDC, Alzheimer's disease, Protein, Point-of-care testing, Growth, WHO, Arecaceae, European Commission, Disease, Microscope, Vaccine, Pharmaceutical industry, Immunofluorescence

Increasing prevalence of chronic and infectious diseases, significant applications of immunofluorescence assay (IFA) in several areas and technological advancements in techniques and associated instruments are key factors driving the market growth.

Key Points: 
  • Increasing prevalence of chronic and infectious diseases, significant applications of immunofluorescence assay (IFA) in several areas and technological advancements in techniques and associated instruments are key factors driving the market growth.
  • The immunofluorescence assay market is anticipated to witness rapid growth, owing to the technological advances and launch of novel instruments.
  • For instance, in November 2020, CTK Biotech, Inc. introduced RaFIA immunofluorescence immunoassay system to meet the rising demand for quantitative rapid tests.
  • Hence, the growing awareness and increasing demand for the detection and cure of several chronic and infectious diseases are some of the driving factors for the market growth.

Global Automated Immunoassay Analyzers Market Report 2022: Increasing Demand for Lab Automation Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 15, 2022
Biotechnology, Hospitals, Pharmaceutical, Health, Therapeutic drug monitoring, Investment, Infection, Geography, SWOT, Ansoff Matrix, Allergy, Viral Research and Diagnostic Laboratories, Market development, Chronic condition, Growth, Research, Risk, Medical device, Immunofluorescence, Endocrinology, Hospital, Application, Radioimmunoassay

The Global Automated Immunoassay Analyzers Market is segmented based on Products, Application, and End User, and Geography.

Key Points: 
  • The Global Automated Immunoassay Analyzers Market is segmented based on Products, Application, and End User, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Automated Immunoassay Analyzers Market.
  • The analyst analyses the Global Automated Immunoassay Analyzers Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Sense and TECOmedical Sign Distribution Agreement for Germany, Austria, Switzerland

Retrieved on: 
Thursday, September 1, 2022
COVID-19, Medical Devices, Infectious Diseases, Health Technology, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Veros, COVID-19, CEO, Interest, WHO, Solution, US, Molecule, Vero Precision Engineering Ltd, Point-of-care testing, Health, CDC, Omicron, Patient, Pharmaceutical industry, Medical device, EU, Immunofluorescence, Delta

Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Senses Veros COVID-19, the first test on the rapid, instrument-free, point-of-care Veros molecular testing platform.

Key Points: 
  • Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Senses Veros COVID-19, the first test on the rapid, instrument-free, point-of-care Veros molecular testing platform.
  • TECOmedical, a Eurobio Scientific Company , is a leading specialty medical distributor with proven success developing new markets with innovative technology.
  • Effective immediately in Germany and Austria, and pending regulatory approval in Switzerland, the agreement is the latest in Senses planned EU distribution partnerships as it commercializes its Veros platform.
  • We are delighted to partner with TECOmedical to bring Veros COVID-19 to the market, building on the impressive reputation that TECOmedical has established with their customers, stated Ryan Roberts, Chief Commercial Officer of Sense.

Research Antibodies and Reagents Global Market Research Report 2022 Featuring Major Players - Abcam, Merck, Cell Signaling Technology, GE Healthcare, Thermo Fisher Scientific - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022
Pharmaceutical, Science, Health, Research, ELISA, COVID-19, Demography, GDP, Forecasting, Flow cytometry, Technology, Growth, Reagent, Application, Geography, Fine chemical, Immunohistochemistry, Immunofluorescence, Immunoprecipitation

The "Research Antibodies and Reagents Global Market Report 2022: By Technology, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Antibodies and Reagents Global Market Report 2022: By Technology, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.
  • Research Antibodies and Reagents Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global research antibodies and reagents market.
  • This report focuses on research antibodies and reagents market which is experiencing strong growth.
  • It compares the research antibodies and reagents market with other segments of the research antibodies and reagents market by size and growth, historic and forecast.

Global Immunofluorescence Assay Market Outlook to 2028 - Key Drivers, Challenges and Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, June 17, 2022
Biotechnology, Pharmaceutical, Health, Private sector, Industry, Omicron, Global, Immunofluorescence, Company, Financial statement analysis, Growth, Region, SWOT, Challenge, Country, Medicinal plants, Microscope, Coke (fuel)

The global Immunofluorescence Assay market size outlook report presents a detailed analysis of the Immunofluorescence Assay markets worldwide including market insights, potential growth opportunities, leading companies, and market developments.

Key Points: 
  • The global Immunofluorescence Assay market size outlook report presents a detailed analysis of the Immunofluorescence Assay markets worldwide including market insights, potential growth opportunities, leading companies, and market developments.
  • The segmentation and outlook are provided across North America Immunofluorescence Assay market (types, Applications), Europe Immunofluorescence Assay market (types, Applications), Asia Pacific Immunofluorescence Assay market (types, Applications), Middle East Immunofluorescence Assay market (types, Applications), Latin America Immunofluorescence Assay market (types, Applications).
  • In particular, key Immunofluorescence Assay market drivers fuelling the Immunofluorescence Assay industry and potential challenges restricting the market outlook are included.
  • The Immunofluorescence Assay market study scope encompasses the below contents:
    Immunofluorescence Assay Market Dynamics - Trends, Drivers, Challenges, Five Forces Analysis
    Immunofluorescence Assay Market Segmentation - Types, Applications at Global and Regional levels
    Immunofluorescence Assay Company Details - Snapshot, SWOT profile, Financial Analysis, Key products

EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

Retrieved on: 
Tuesday, March 16, 2021
Hardware, Data management, Technology, Pharmaceutical, General Health, Medical devices, Hospitals, Clinical trials, Other Technology, Science, Biotechnology, Software, Other Science, Health, Research, Branches of biology, Biology, Life sciences, Microscopes, Immunologic tests, Laboratory equipment, Laboratory techniques, Anatomical pathology, Immunofluorescence, Fluorescence microscope, Microscopy, PerkinElmer

EUROIMMUN , a PerkinElmer, Inc. company, today announced the launch of the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Companys well-established EUROLabOfficeTM 4.0 (ELO 4.0) laboratory management software.

Key Points: 
  • EUROIMMUN , a PerkinElmer, Inc. company, today announced the launch of the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Companys well-established EUROLabOfficeTM 4.0 (ELO 4.0) laboratory management software.
  • The combined system of hardware and software allows for ultrafast automated immunofluorescence image acquisition, pattern recognition and titer estimation as well as modern diagnostics at the screen.
  • Traditional interpretation of IIFT results under the fluorescence microscope is a time-consuming process that requires a dark room and experienced staff.
  • The introduction of automated microscopy in diagnostic routines eliminates these challenges and supports standardization of IIFT result interpretation.

Global Immunofluorescence Assay Market (2020 to 2026) - Increasing Government Funding for Life Science Research is Driving Growth

Retrieved on: 
Tuesday, February 16, 2021
Medical specialties, Branches of biology, Biology, Laboratory techniques, Immunologic tests, Immunology, Biotechnology, Assay, Titration, Monoclonal antibody, Immunofluorescence

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

Key Points: 
  • Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.
  • The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast period
    The Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.
  • The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020.
  • Factors such as improving healthcare infrastructure, increasing healthcare spending, and favorable government initiatives are driving the growth of the immunofluorescence assay market in Asia-Pacific.

The Worldwide Immunofluorescence Assay Industry is Expected to Reach $3.5 Billion by 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 15, 2021
Health, Biotechnology, Branches of biology, Medical specialties, Immunologic tests, Laboratory techniques, Natural sciences, Direct fluorescent antibody, Immunofluorescence, Assay

The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6% during the forecast period.

Key Points: 
  • The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6% during the forecast period.
  • Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.
  • The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast period
    The Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.
  • Based on type, the immunofluorescence assays market is segmented into indirect immunofluorescence and direct immunofluorescence.

Immunofluorescence Assay Market worth $3.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, February 3, 2021
Medical specialties, Clinical medicine, Branches of biology, Immunologic tests, Autoantibodies, Chemical pathology, Biotechnology, Anatomical pathology, Immunofluorescence, Anti-SSA/Ro autoantibodies, Monoclonal antibody

Emerging markets are expected to provide growth opportunities for players operating in the Immunofluorescence instruments market in the coming years.

Key Points: 
  • Emerging markets are expected to provide growth opportunities for players operating in the Immunofluorescence instruments market in the coming years.
  • By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.
  • Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases.
  • The Immunofluorescence instruments market is divided into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Immunofluorescence Assay Market worth $3.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, February 3, 2021
Medical specialties, Clinical medicine, Branches of biology, Immunologic tests, Autoantibodies, Chemical pathology, Biotechnology, Anatomical pathology, Immunofluorescence, Anti-SSA/Ro autoantibodies, Monoclonal antibody

Emerging markets are expected to provide growth opportunities for players operating in the Immunofluorescence instruments market in the coming years.

Key Points: 
  • Emerging markets are expected to provide growth opportunities for players operating in the Immunofluorescence instruments market in the coming years.
  • By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.
  • Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases.
  • The Immunofluorescence instruments market is divided into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.